{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:29:23Z","timestamp":1792819763716,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ymthe.2026.08.006","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:44:43Z","timestamp":1786376683000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The DreAM-plus integrative RNA switch enhances transient AAV expression and reduces side effects of gene editing"],"prefix":"10.1016","author":[{"given":"Yueyang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanzhao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhe","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonglie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengying","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaohua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6009-4403","authenticated-orcid":false,"given":"Yuxuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.08.006_bib1","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery","volume":"18","author":"Wang","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2026.08.006_bib2","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa2107454","article-title":"CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis","volume":"385","author":"Gillmore","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.08.006_bib3","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1056\/NEJMoa2309676","article-title":"Exagamglogene Autotemcel for Severe Sickle Cell Disease","volume":"390","author":"Frangoul","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.08.006_bib4","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa2309673","article-title":"Exagamglogene Autotemcel for Transfusion-Dependent \u03b2-Thalassemia","volume":"390","author":"Locatelli","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.08.006_bib5","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41573-021-00162-z","article-title":"Antisense technology: an overview and prospectus","volume":"20","author":"Crooke","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2026.08.006_bib6","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/s41573-024-00977-6","article-title":"The 60-year evolution of lipid nanoparticles for nucleic acid delivery","volume":"23","author":"Cullis","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2026.08.006_bib7","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1038\/s44161-025-00744-9","article-title":"Gene therapy CM-YAP(on) protects the mouse heart from myocardial infarction","volume":"4","author":"Meng","year":"2025","journal-title":"Nat. Cardiovasc. Res."},{"key":"10.1016\/j.ymthe.2026.08.006_bib8","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/s44161-025-00665-7","article-title":"The drug-elicitable alternative splicing module for tunable vector expression in the heart","volume":"4","author":"Chen","year":"2025","journal-title":"Nat. Cardiovasc. Res."},{"key":"10.1016\/j.ymthe.2026.08.006_bib9","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1038\/s41587-023-01989-0","article-title":"Control of mammalian gene expression by modulation of polyA signal cleavage at 5' UTR","volume":"42","author":"Luo","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.08.006_bib10","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1038\/s41467-023-37829-7","article-title":"Engineered CRISPR-OsCas12f1 and RhCas12f1 with robust activities and expanded target range for genome editing","volume":"14","author":"Kong","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.08.006_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1143157","article-title":"Off-target effects in CRISPR\/Cas9 gene editing","volume":"11","author":"Guo","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.08.006_bib12","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.omtm.2021.02.005","article-title":"In vivo PCSK9 gene editing using an all-in-one self-cleavage AAV-CRISPR system","volume":"20","author":"Li","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.08.006_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101365","article-title":"Comprehensive analysis of off-target and on-target effects resulting from liver-directed CRISPR-Cas9-mediated gene targeting with AAV vectors","volume":"32","author":"Singh","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.08.006_bib14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.omtm.2018.11.009","article-title":"A Self-Deleting AAV-CRISPR System for In Vivo Genome Editing","volume":"12","author":"Li","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.08.006_bib15","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1016\/j.ymthe.2025.06.045","article-title":"Peeling back the layers of immunogenicity in Cas9-based genomic medicine","volume":"33","author":"Stigzelius","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.08.006_bib16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41467-024-55522-1","article-title":"Rational engineering of minimally immunogenic nucleases for gene therapy","volume":"16","author":"Raghavan","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.08.006_bib17","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nmeth.3993","article-title":"A multifunctional AAV-CRISPR-Cas9 and its host response","volume":"13","author":"Chew","year":"2016","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymthe.2026.08.006_bib18","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.ymthe.2020.04.017","article-title":"AAV-CRISPR Gene Editing Is Negated by Pre-existing Immunity to Cas9","volume":"28","author":"Li","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.08.006_bib19","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41591-018-0326-x","article-title":"Identification of preexisting adaptive immunity to Cas9 proteins in humans","volume":"25","author":"Charlesworth","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.08.006_bib20","doi-asserted-by":"crossref","first-page":"6769","DOI":"10.1038\/s41467-021-26830-7","article-title":"Cas9-specific immune responses compromise local and systemic AAV CRISPR therapy in multiple dystrophic canine models","volume":"12","author":"Hakim","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.08.006_bib21","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/s41591-018-0204-6","article-title":"High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population","volume":"25","author":"Wagner","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.08.006_bib22","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.1073\/pnas.89.12.5547","article-title":"Tight control of gene expression in mammalian cells by tetracycline-responsive promoters","volume":"89","author":"Gossen","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.08.006_bib23","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.addr.2008.12.016","article-title":"In vivo gene regulation using tetracycline-regulatable systems","volume":"61","author":"Stieger","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ymthe.2026.08.006_bib24","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/mt.2011.37","article-title":"Development of a liver-specific Tet-on inducible system for AAV vectors and its application in the treatment of liver cancer","volume":"19","author":"Vanrell","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.08.006_bib25","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaf345","article-title":"Dynamic activation of rAAV transgene expression by a small molecule that recruits endogenous transcriptional machinery","volume":"53","author":"Wasserman","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2026.08.006_bib26","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41586-021-03770-2","article-title":"Regulated control of gene therapies by drug-induced splicing","volume":"596","author":"Monteys","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.08.006_bib27","article-title":"A compact, versatile drug-induced splicing switch system with minimal background expression","volume":"4","author":"Chi","year":"2024","journal-title":"Cell Rep. Methods"},{"key":"10.1016\/j.ymthe.2026.08.006_bib28","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1038\/s41592-025-02860-7","article-title":"A portable poison exon for small-molecule control of mammalian gene expression","volume":"22","author":"Hou","year":"2025","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymthe.2026.08.006_bib29","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41587-019-0357-y","article-title":"A reversible RNA on-switch that controls gene expression of AAV-delivered therapeutics in vivo","volume":"38","author":"Zhong","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.08.006_bib30","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1021\/acssynbio.9b00410","article-title":"A Small-Molecule-Responsive Riboswitch Enables Conditional Induction of Viral Vector-Mediated Gene Expression in Mice","volume":"9","author":"Strobel","year":"2020","journal-title":"ACS Synth. Biol."},{"key":"10.1016\/j.ymthe.2026.08.006_bib31","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.chembiol.2010.07.009","article-title":"A general chemical method to regulate protein stability in the mammalian central nervous system","volume":"17","author":"Iwamoto","year":"2010","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ymthe.2026.08.006_bib32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nchembio.2224","article-title":"Multidimensional chemical control of CRISPR-Cas9","volume":"13","author":"Maji","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ymthe.2026.08.006_bib33","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41587-025-02610-2","article-title":"Engineering a photoactivatable A-to-I RNA base editor for gene therapy in vivo","volume":"44","author":"Li","year":"2026","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.08.006_bib34","doi-asserted-by":"crossref","first-page":"9897","DOI":"10.1038\/s41467-025-65808-7","article-title":"Beyond the niche - unlocking the full potential of synthetic riboswitches","volume":"16","author":"Hoetzel","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.08.006_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102172","article-title":"Temporal restriction of Cas9 expression improves CRISPR-mediated deletion efficacy and fidelity","volume":"35","author":"Weber","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2026.08.006_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-68183-5","article-title":"A compact and inducible dCas12f-based CRISPRa platform for programmable in vivo gene activation","volume":"17","author":"Wan","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.08.006_bib37","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1101\/gad.353718.126","article-title":"The competition between splicing and 3' processing shapes the human transcriptome","volume":"40","author":"Soles","year":"2026","journal-title":"Genes Dev."},{"key":"10.1016\/j.ymthe.2026.08.006_bib38","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1038\/s41467-020-17222-4","article-title":"Large-scale DNA-based phenotypic recording and deep learning enable highly accurate sequence-function mapping","volume":"11","author":"H\u00f6llerer","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.08.006_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.113544","article-title":"Enhancing mRNA translation efficiency with discriminative and generative artificial intelligence by optimizing 5' UTR sequences","volume":"28","author":"Liu","year":"2025","journal-title":"iScience"},{"key":"10.1016\/j.ymthe.2026.08.006_bib40","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/s41587-019-0164-5","article-title":"Human 5' UTR design and variant effect prediction from a massively parallel translation assay","volume":"37","author":"Sample","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.08.006_bib41","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1101\/gad.350752.123","article-title":"Translational regulation by uORFs and start codon selection stringency","volume":"37","author":"Dever","year":"2023","journal-title":"Genes Dev."},{"key":"10.1016\/j.ymthe.2026.08.006_bib42","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020104763","article-title":"Translation of small downstream ORFs enhances translation of canonical main open reading frames","volume":"39","author":"Wu","year":"2020","journal-title":"Embo j"},{"key":"10.1016\/j.ymthe.2026.08.006_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/pro.70036","article-title":"Translation of the downstream ORF from bicistronic mRNAs by human cells: Impact of codon usage and splicing in the upstream ORF","volume":"34","author":"Paget-Bailly","year":"2025","journal-title":"Protein Sci."},{"key":"10.1016\/j.ymthe.2026.08.006_bib44","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0025-7125(16)30039-6","article-title":"Tetracyclines","volume":"79","author":"Klein","year":"1995","journal-title":"Med. Clin. North Am."},{"key":"10.1016\/j.ymthe.2026.08.006_bib45","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s40263-022-00910-8","article-title":"Risdiplam: A Review in Spinal Muscular Atrophy","volume":"36","author":"Paik","year":"2022","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ymthe.2026.08.006_bib46","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41587-021-01009-z","article-title":"Efficient CRISPR editing with a hypercompact Cas12f1 and engineered guide RNAs delivered by adeno-associated virus","volume":"40","author":"Kim","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.08.006_bib47","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ymthe.2025.10.005","article-title":"Gene supplementation with precise transgene expression rescues hearing loss in a mouse model with an Mpzl2 East Asian founder variant","volume":"34","author":"Jang","year":"2026","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.08.006_bib48","doi-asserted-by":"crossref","first-page":"641","DOI":"10.5966\/sctm.2013-0017","article-title":"Sustained knockdown of a disease-causing gene in patient-specific induced pluripotent stem cells using lentiviral vector-based gene therapy","volume":"2","author":"Eggenschwiler","year":"2013","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.ymthe.2026.08.006_bib49","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1161\/CIRCULATIONAHA.123.065438","article-title":"MicroRNA-122-Mediated Liver Detargeting Enhances the Tissue Specificity of Cardiac Genome Editing","volume":"149","author":"Yang","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.ymthe.2026.08.006_bib50","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/gt.2010.105","article-title":"Robust cardiomyocyte-specific gene expression following systemic injection of AAV: in vivo gene delivery follows a Poisson distribution","volume":"18","author":"Prasad","year":"2011","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2026.08.006_bib51","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/gt.2010.141","article-title":"microRNA122-regulated transgene expression increases specificity of cardiac gene transfer upon intravenous delivery of AAV9 vectors","volume":"18","author":"Geisler","year":"2011","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2026.08.006_bib52","doi-asserted-by":"crossref","first-page":"D914","DOI":"10.1093\/nar\/gkae1025","article-title":"CRISPRoffT: comprehensive database of CRISPR\/Cas off-targets","volume":"53","author":"Wang","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2026.08.006_bib53","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature14299","article-title":"In vivo genome editing using Staphylococcus aureus Cas9","volume":"520","author":"Ran","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.08.006_bib54","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1093\/bioinformatics\/btu048","article-title":"Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases","volume":"30","author":"Bae","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ymthe.2026.08.006_bib55","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/s41551-019-0431-2","article-title":"Immune-orthogonal orthologues of AAV capsids and of Cas9 circumvent the immune response to the administration of gene therapy","volume":"3","author":"Moreno","year":"2019","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.ymthe.2026.08.006_bib56","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/j.ymthe.2025.12.042","article-title":"Transgene-induced cardiotoxicity in high-dose AAV gene transfer","volume":"34","author":"Biquand","year":"2026","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.08.006_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101474","article-title":"Evaluation of the loading capacity and patterns of packaged DNA in AAV genomes of different sizes using long-read sequencing","volume":"33","author":"Kosaka","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.08.006_bib58","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1007\/s11427-023-2608-5","article-title":"AAV-mediated gene therapies by miniature gene editing tools","volume":"67","author":"Kong","year":"2024","journal-title":"Sci. China. Life Sci."},{"key":"10.1016\/j.ymthe.2026.08.006_bib59","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1038\/s41592-024-02418-z","article-title":"Effective genome editing with an enhanced ISDra2 TnpB system and deep learning-predicted \u03c9RNAs","volume":"21","author":"Marquart","year":"2024","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymthe.2026.08.006_bib60","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41587-019-0032-3","article-title":"CRISPResso2 provides accurate and rapid genome editing sequence analysis","volume":"37","author":"Clement","year":"2019","journal-title":"Nat. Biotechnol."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626006878?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626006878?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:39:29Z","timestamp":1787312369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626006878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":60,"alternative-id":["S1525001626006878"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.08.006","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The DreAM-plus integrative RNA switch enhances transient AAV expression and reduces side effects of gene editing","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}